New Zealand Gazette – 1997 – No. 29

Page 706

✨ Medicines Approval



NEW ZEALAND GAZETTE

No. 29

Health

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Sodium chloride 0.9 g per 100 mL in 10 mL, 20 mL Solution, infusion, ampoule B Braun Pharmaceutical Industries Snd Bhd, Bayan Lepas, Penang, Malaysia 0.9% Sodium Chloride
Sodium chloride 0.9 g per 100 mL in 250 mL, 500 mL, 1000 mL Solution, infusion, bottle B Braun Pharmaceutical Industries Snd Bhd, Bayan Lepas, Penang, Malaysia 0.9% Sodium Chloride
Dextrose monohydrate 5.0 g, sodium chloride 0.9 g per 100 mL in 500 mL, 1000 mL Solution, infusion, bottle B Braun Pharmaceutical Industries Snd Bhd, Bayan Lepas, Penang, Malaysia 0.9% Sodium Chloride & 5% Glucose Injection
Dextrose monohydrate 50.0 g per 100 mL in 100 mL, 250 mL, 500 mL, 1000 mL Solution, infusion, bottle B Braun Pharmaceutical Industries Snd Bhd, Bayan Lepas, Penang, Malaysia 5% Glucose Intravenous Infusion
Amoxycillin trihydrate 500 mg, clavulanate potassium 125 mg Tablet Lek Pharmaceutical & Chemical Co., Ljubljana, Slovenia Amoxyclav
Day-time component: Benadryl Day & Night
Dextromethorphan hydrobromide 10 mg/5 mL, pseudoephedrine hydrochloride 30 mg/5 mL in 100 mL Syrup Parke-Davis Pty Limited, Caringbah, New South Wales, Australia
Night-time component:
Dextromethorphan hydrobromide 10 mg/5 mL, diphenhydramine hydrochloride 12.5 mg/5 mL, pseudoephedrine hydrochloride 30 mg/5 mL in 100 mL Syrup Parke-Davis Pty Limited, Caringbah, New South Wales, Australia
Bupivacaine hydrochloride anhydrous equivalent to 0.25% w/v, 0.5% w/v bupivacaine hydrochloride Injection, solution, ampoule Antigen Pharmaceuticals Limited, Roscrea, Co Tipperary, Ireland Bupivacaine Hydrochloride
Potassium chloride 0.27 g, sodium chloride 0.4 g, sodium lactate 0.58 g per 100 mL in 500 mL, 1000 mL Solution, infusion, bottle B Braun Pharmaceutical Industries Snd Bhd, Bayan Lepas, Penang, Malaysia Darrow's Solution
Doxylamine succinate 25 mg Capsule R P Scherer Holdings Pty Limited, Braeside, Victoria, Australia Dozile
Component 1: Tablets Solvay Duphar bv., Olst, The Netherlands Femoston 2/10
oestradiol 2 mg
Component 2:
oestradiol 2 mg, dydrogesterone 10 mg
Calcium chloride dihydrate 0.027 g, potassium chloride 0.04 g, sodium chloride 0.6 g, sodium lactate 0.312 g per 100 mL in 500 mL, 1000 mL Solution, infusion, bottle B Braun Pharmaceutical Industries Snd Bhd, Bayan Lepas, Penang, Malaysia Hartmann's Solution
100IU, 400IU Hepatitis B immunoglobulin in a 16% w/v solution of IgG Injection, solution, vial C S L Limited, Broadmeadows, Victoria, Australia Hepatitis B Immunoglobulin
625IU (125 mcg) Rh (D) immunoglobulin per mL in a 16% w/v solution of IgG Injection, solution, vial C S L Limited, Broadmeadows, Victoria, Australia Rh (D) Immunoglobulin
250IU Tetanus antitoxin in a 16% w/v solution of IgG Injection, solution, vial C S L Limited, Broadmeadows, Victoria, Australia Tetanus Immunoglobulin


Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa — PDF NZ Gazette 1997, No 29


NZLII — PDF NZ Gazette 1997, No 29




✨ LLM interpretation of page content

🏥 Consent to Distribution of New Medicines

🏥 Health & Social Welfare
Medicines Act, Approval, Pharmaceuticals, Distribution